Organizers

The International Pancreas and Islet Transplantation Association aims to serve the pancreas and islet transplant scientific community in providing a forum for the open exchange of knowledge and expertise in order to facilitate the advancement of the clinical practice of pancreas and islet transplantation for the treatment of human diabetes.

AIMS OF THE ASSOCIATION

To promote and encourage research and training relevant to transplantation of insulin producing tissue in the treatment and cure of diabetes mellitus.
To provide a scientific forum for the exchange and discussion of clinical and experimental results and experiences relevant to transplantation of insulin producing tissue in the treatment and cure of diabetes mellitus.
To promote and encourage contacts between clinical and experimental researchers from different institutions and from all pertinent disciplines.

Visit the IXA's Website

The International Xenotransplantation Association (IXA) was established at the Montreal '98 Congress of The Transplantation Society, with the aim of providing a forum for those with a special interest in Xenotransplantation.

The IXA’s core mission is closely aligned with the principles outlined in the Cartagena Protocol on Biological Diversity. This international agreement describes international norms for the use of genetically modified animals “to contribute to the development of human welfare and the promotion of environmental conservation on a global basis.” The Cartagena Protocol specifically seeks to “promote access to and transfer of technologies, including biotechnology” for the advancement of human health, and “to ensure the development of appropriate procedures to enhance the safety of biotechnology in the context of the Convention’s overall goal of reducing all potential threats to biological diversity, taking also into account the risks to human health.”

MISSION

The IXA’s mission is to promote xenotransplantation as a safe, ethical, and effective therapeutic modality by:

fostering the science of xenotransplantation through promotion of ethical clinical and pre-clinical research, productive discourse, and collaboration.
educating health care providers and lay persons through broad, representative participation in interactive public debate.
guiding the development of scientifically sound, internationally consistent public policy that is responsive to new developments in the field and acknowledges varying social, ethical and legal frameworks.

For more information visit the

IXA Website

Visit CTRMS's Website

The Cell Transplant and Regenerative Medicine Society exists to be the leader in developing and translating, safe cellular and regenerative therapies to patients. The Society will promote research, collaboration and focus on regulatory matters, as they relate to clinical translation.

OBJECTIVES

The Society shall promote and encourage education and research with respect to cellular transplantation and regenerative medicine.
The Society shall collaborate with existing public and private organizations to promote and encourage education and research in cellular transplantation and regenerative medicine and will participate and assist in the coordination of efforts or formulation of research and clinical programs.

Visit TTS's Website

The Transplantation Society is a non-profit NGO providing global leadership in transplantation.

TTS mission is to provide global leadership in the practice of human transplantation. The responsibility of TTS is to establish guidelines of clinical practice, advance programs of education, and to promote ethical standards for clinical care and scientific investigation.

6700+ Members composed of professionals with an active interest in basic science, clinical research and/or improving clinical practice in the field of transplantation. With 105+ countries represented, TTS is a diverse international Society with members across the globe.

Transplantation, the Official Journal of The Transplantation Society is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations a year.

TTS biennial congress brings together over 5000 participants from across the globe.

Visit Scripp's Website

A leader in the prevention, diagnosis and treatment of diseases.

Scripps Health is a $2.9 billion private, nonprofit, integrated health system in San Diego, California that is ranked among the top 15 health systems in the nation. Scripps treats 700,000 patients annually.

The organization encompasses:

Four hospitals on five campuses.
More than 3,000 affiliated physicians and 15,000 employees.
Scripps Clinic and Scripps Coastal Medical Center, a network of integrated facilities with specialists from more than 60 medical and surgical specialties at more than 28 outpatient centers and clinics.
Same-day, walk-in care at Scripps Health Express.
Four emergency rooms and three urgent care centers.
Home health care.
A wide range of health education classes and support services.

Founded in 1924 by philanthropist Ellen Browning Scripps in the community of La Jolla, the health system now extends from Chula Vista to Oceanside. It is consistently recognized for providing high quality health care. Learn more about the organization’s awards and accolades.

A new era in medicine

On the forefront of genomic medicine and wireless health technology, Scripps is dedicated to improving community health while advancing medicine through clinical research and graduate medical education.